Catalyst Health Economics Consultants

Cost-effectiveness of pentostatin compared to cladribine in the management of hairy cell leukaemia in the UK.

Presented at the 49th meeting of the British Society of Haematology, Brighton, April 2009.


<<< Go Back

Catalyst Health Economics Consultants Ltd
© 1991 - 2010